Skip to main content

Table 2 Baseline characteristics and clinical outcomes in patients with and without GFI

From: Incidence and risk factors of nasogastric feeding intolerance in moderately-severe to severe acute pancreatitis

 

GFI group (n = 24)

Non-GFI group (n = 69)

P

Age

40 (33–48)

40 (33–48)

0.954

Male

13 (54.2)

50 (72.5)

0.099

BMI

26.2 (23.6–28.4)

26.1 (24.1–30.1)

0.706

APACHE II

10 (7–11)

7 (5–10)

0.003

Time from onset of abdominal pain to study hospital admission

4 (1–4)

3 (2–5)

0.771

RAC

  

 < 0.001

 Moderate

8 (33.3)

60 (87)

 

 Severe

16 (66.7)

9 (13)

 

Etiology

  

0.565

 Hypertriglyceridemia

12 (50)

31 (44.9)

 

 Biliary

10 (41.7)

26 (37.7)

 

 Others

2 (8.3)

12 (17.4)

 

Systemic complications at hospital admission

   

 Respiratory failure

16 (66.7)

23 (33.3)

0.004

 AKI

5 (20.8)

2 (2.9)

0.016

 Shock

2 (8.3)

1 (1.4)

0.162

Clinical outcomes

   

 Energy target-reaching rate between day3-day7

12 (50)

61 (88.4)

 < 0.001

 Hospital mortality

1 (4.2)

0 (0)

0.258

 Length of hospital stay, day

18 (9–31)

6 (4–9)

 < 0.001

 Pancreaticocutaneous fistula

1 (4.2)

0 (0)

0.258

 Abdominal bleeding

2 (8.3)

0 (0)

0.065

 IPN

3 (12.5)

0 (0)

0.016

New receipt of organ support therapy

   

 MV

2 (8.3)

1 (1.4)

0.162

 Vasopressors

1 (4.2)

0 (0)

0.258

Mean total inpatient hospital costs, k¥

88.2 (42.2–16.2)

29.4 (22.3–42.0)

 < 0.001

  1. Data are presented as n (%) or median (interquartile range)
  2. BMI Body mass index, RAC Revised atlanta criteria, APACHE II Acute physiology and chronic health evaluation II, AKI Acute kidney injury, GFI Gastric feeding intolerance, IPN Infected pancreatic necrosis, MV Mechanical ventilation